Today's Daily Dose brings you news about AC Immune's disappointing results in Alzheimer's trial, Actinium Pharma's progress in the Acute Myeloid Leukemia study, Johnson & Johnson initiating phase III trial of its COVID-19 vaccine candidate, and Pfizer's regulatory catalyst.
from RTT - Biotech https://ift.tt/3crTY6j
via IFTTT
No comments:
Post a Comment